View the NewsRx Library

Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Pharma Business Week

Susan Hasty, Publisher
Table of Contents . . . August 15th, 2005
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Pharma Business Week | Other Publications

Business Update - Companies to pay $525M to purchase Emory's emtricitabine royalty interest

Drug Development - Emezine NDA accepted for review by U.S. FDA

Drug Development - Encouraging early data from Parkinson disease trial reported

Drug Development - Recruitment completed for Betaseron BEYOND study

Head Lice - PerFoam demonstrates safety and 96% efficacy in phase II/III study

Mergers & Acquisitions - European Commission clears Gillette merger

Addiction Medicine - Cozart RapiScan drug test detects cocaine and opiates in oral fluid

Adverse Drug Reaction - Agency issues public health advisory on transdermal fentanyl patches

Adverse Drug Reaction - Four reported deaths prompt warning about Mifeprex

Advocacy - DTC voluntary Guiding Principles receive association board preliminary approval

Age-Related Macular Degeneration - Age-related macular degeneration trial data presented at conference

Age-Related Macular Degeneration - Results from phase III MARINA study reported

Allergy & Immunology - Asthma and allergy sufferers need to be on high alert while traveling

Allergy & Immunology - FDA OKs reformulated Clarinex orally disintegrating prescription antihistamine

Allergy Testing - Colorimetric microarray assay for allergen-responsive IgE developed

Alzheimer Disease - Drug development company announces publication of Alzheimer preclinical studies

Anesthesia - Pennsylvania surgery centers sign agreement for anesthesia services

Anthrax - Final EPA protocol testing of anthrax sporicidal completed

Anthrax - Researchers describe findings in anthrax studies

Anthrax - Results published of phase I trial of ABthrax to prevent, treat anthrax

Antibacterial Agents - Safe4Hours lotion rolled out to school systems

Atherosclerosis - Drug-discovery company appoints new scientific advisory board

Atrial Fibrillation - ACT 3 atrial fibrillation trial enrollment completed

Attention Deficit Hyperactivity Disorder - Dopamine transporter genotype affects methylphenidate efficacy

Attention Deficit Hyperactivity Disorder - U.S. Patent office sends allowance for attention deficit, hyperactivity drug

Audiology - Untreated hearing loss costs $100 billion yearly in lost income, new data show

Avian Influenza - Vietnam to begin testing VIRA 38 against the bird flu virus

Awards - Company receives award for technology in noninvasive blood pressure market

Awards - Foundation announces Albert Szent-Gyorgyi Prize for Progress in Cancer Research

Awards - Medical products company named Equipment Manufacturer of the Year by distributor

Awards - Provider to pharmaceutical firms receives The Entrepreneurial Company Award

Awards - Robert Porr receives ACHE Healthcare Executive Regent's Award

Awards - Urinalysis device maker gets award

Biotechnology - FDA requests additional data on PULMINIQ

Bioterrorism - Experts call for overseeing of BioShield procurements

Bioterrorism - Milestone reached in the development and manufacture of RiVax

Bioterrorism - Walter Reed Army institute, pharmaceutical company sign research agreement

Bipolar Disorder - Divalproex comparable to lithium in efficacy and cost

Breast Cancer - Australian-based biotech company identifies new breast cancer target protein

Breast Cancer - Cost-effectiveness of monoclonal antibody evaluated for metastatic breast cancer

Business & Finance - Biopharmaceutical company reports second quarter 2005 results

Business & Finance - Biopharmaceutical company reports underwriter exercise of over-allotment option

Business & Finance - Bioprocess and bioscience company reports second quarter revenues

Business & Finance - Biosciences company provides ECO-4601 update

Business & Finance - Biosciences company secures $35 million line of credit from California bank

Business & Finance - Company gets payment as part of deal to assign portion of Aeres to Syngenta

Business & Finance - Healthcare software company expects second quarter revenue of $3.8-$4.0 million

Business & Finance - Life science company reports record operating results

Business & Finance - Medical device company named to Russell 3000, 2000 and Microcap indexes

Business & Finance - Medical device maker files option plan for CEO

Business & Finance - Microbiology product maker provides trading update

Business & Finance - Pharmaceutical company announces second-quarter 2005 earnings per share

Business & Finance - Pharmaceutical company reports 2005 second quarter financial results

Business & Finance - Pharmaceutical company reports first quarter financial results

Business Update - ASP adds business worth $3.2 million

Business Update - Angle Technology Group chosen to conduct state bioscience assessment

Business Update - Australian cGMP manufacturing facility opened

Business Update - Biopharmaceutical company retakes control of BPI product from Zephyr Sciences

Business Update - Breast implant provider secures two distribution agreements

Business Update - Chemical manufacturer appointed by MNLpharma

Business Update - Company announces first U.S. implant of VentrAssist

Business Update - Company completes agreement with Unimarck

Business Update - Company inks HAP Technology license agreement with Organon

Business Update - Company to amend EP-2104R clinical trial protocols

Business Update - Company's center of excellence passes ISO 9001:2000 recertification audit

Business Update - Diverse health products company forms strategic relationship with XL TechGroup

Business Update - Diversity departments face challenge in diversity and inclusion programs

Business Update - First orders of ceftriaxone injection shipped

Business Update - Increased demand for astaxanthin will be met

Business Update - Laparoscopic systems company adds medical technology companies to portfolio

Business Update - Manufacturing agreement signed for Ergothioneine

Business Update - Nutritional supplements provider opens network marketing in Germany

Business Update - Pharma company announces new headquarters and laboratory location

Business Update - Pharmaceutical company changes name to reflect corporate growth

Business Update - Pharmaceutical firm receives inspectional observations from U.S. FDA

Business Update - Pharmaceutical firm retains CIBC World Markets as strategic advisor

Business Update - Pharmaceutical, biotech execs form independent professional association ISMPP

Business Update - Pharmaceuticals company closes sale of global biologics manufacturing business

Business Update - Positive news reported from Betac product recall investigation

Business Update - Sale of Vaculok discontinued line assets announced by lab services company CEO

Business Update - Stem cell group creates governance subcommittee

Business Update - West Michigan health system breaks ground on Lemmen-Holton Cancer Pavilion

Business Update - Xanodyne Pharmaceuticals makes winning bid to sell pharmaceuticals division

Cancer Research - Clinical trial for treatment of chemotherapy-induced anemia on hold

Cancer Research - Final clearance for phase 1 clinical trial for PV-10 obtainted

Cancer Research - ProQinase and Univ. of Duesseldorf receive grant for anticancer drug research

Cancer Therapy - INGN 241 cancer therapy triggers immune system to kill cancer cells

Cancer Therapy - Phase I clinical trial begins for CX-3543, a multiple-cancer therapy

Cancer Therapy - Phase II study initiated with oral Fosfluridine in actinic keratosis

Cancer Therapy - Preclinical data demonstrate direct checkpoint activation kills cancer cells

Cancer Vaccines - Company inks agreement with Merck for cancer vaccines targeting telomerase

Cardiovascular Disease - Women unaware of differences in bad and good cholesterol, survey shows

Clinical Trials - Challenges in systematic reviews that assess treatment harms outlined

Clinical Trials - IDE submitted for vascular closure system in preparation for clinical trial

Clinical Trials - Pharma firm posts information on clinical trials on the Internet

Clinical Trials - Phase 1 trial results of potential treatment for GERD and spacticity announced

Clinical Trials - Phase 2 clinical trial for hemoglobin-based blood alternative Hemospan initiated

Clinical Trials - Postoperative analgesia for infusion found to be effective, company announces

Cocaine Vaccine - Glyceride adjuvant induces protective antibodies against cocaine

Collaborations - Agreement signed for sale of U.S., Canadian consumer medicines business

Collaborations - Alliance to discover, develop reverse cholesterol transport enhancing compounds

Collaborations - Biosoftware company and GeneGo to offer interoperability

Collaborations - CRO announces collaboration with Scripps Florida

Collaborations - Collaboration agreement signed with Centocor, Inc. to create improved antibodies

Collaborations - Companies renew agreement to make mammography CAD technology more available

Collaborations - Contract manufacturer and research company announce collaboration

Collaborations - Deal signed with Japanese firms to develop anticancer therapeutic

Collaborations - Medical information provider, software developer form marketing alliance

Collaborations - Proteomics company enters research agreement with research institute

Collaborations - Research collaboration to study genetic causes of disease

Collaborations - Supply and marketing partnership signed by microarray companies

Collaborations - i-PROT labeling technology licensed to proteomics service provider

Complementary and Alternative Medicine - Study suggests flavanol products might lower blood pressure

Dermatology - Advancing the treatment of skin conditions at the speed of light

Dermatology - Dermatologist addresses academy session on common nail problems

Dermatology - Dermatologists give advice on maintaining healthy hair

Dermatology - Dermatology organization discuss sunscreen benefits, pre-cancer protection

Dermatology - Hylexin eliminates dark circles under the eye

Diabetes Therapy - Development of CS-917 for the treatment of type 2 diabetes to resume

Diabetes Therapy - HPB-84 available for immediate shipment nationwide

Diabetes Therapy - Phase 3 study for inhaled insulin system initiated

Diagnostics - Respiratory pathogens rapidly identified/typed for epidemic surveillance

Diagnostics - U.S. distribution partner for heart, blood vessel assessment device announced

Diet and Nutrition - Beano introduces recommendations to accompany USDA dietary guidelines

Diet and Nutrition - Protandim dietary supplement to be available at GNC stores

Drug Abuse - Treatment admissions sharply up for methamphetamine, narcotic pain medications

Drug Delivery - Publication of key animal study results with chemotherapy adjuvant announced

Drug Development - AERx HCQ program moves into phase II trials

Drug Development - Animal studies completed for IFN-beta variants

Drug Development - Company appoints Charles Homcy to its board of directors

Drug Development - Drug developer sets $15 million financing, renin inhibitor collaboration

Drug Development - Female hormone product development completed; distribution contracted

Drug Development - Final approval granted for hydrochlorothiazide capsules 12.5 mg

Drug Development - Hepatitis C drug discovery collaboration expanded

Drug Development - Humira receives positive opinion from the European Medicines Agency

Drug Development - IND filed with U.S. FDA for pivotal phase III trial of antifungal agent

Drug Development - MVA3000 phase II trial commences for smallpox indication

Drug Development - Merck reaches clinical development milestone with adenovirus vaccine candidate

Drug Development - Pharmaceutical company files ANDA for injectable anticancer drug

Drug Development - Phase I/II trial of Lewis Y-specific antibody initiated

Drug Development - Phase II trial with Imvamune in HIV infected patients initiated

Drug Development - Phase IIb trial of cetilistat begins in obese diabetic patients

Drug Development - Quantum mechanical polarizable force field devised for biomolecular systems

Drug Development - Randomization completed for phase III TRIUMPH efficacy trial of Eculizumab

Drug Development - U.S. FDA grants clearance for Parallax Acrylic Resin with TRACERS-Ta

Drug Development - U.S. NIH awards $1.49 million grant to prepare blood clot drug for human trials

Drug Development - U.S. SBIR grant awarded for manufacturing antibodies in transgenic plants

Drug Development - Vista Partners initiates research coverage of anti-cancer drug company

Drug Safety - Pharmacists offer tips to help patients avoid medication errors

Drug Safety - RxWise launched as portable medication safety checking system

Drug Safety - Safety notice issued concerning products containing Coleus Forskolii

Drug Safety - U.S. FDA requests opioid drug label changes from pharmaceutical company

Ebola - Agreement signed to evaluate Tarvacin for hemorrhagic disease

Electronic Medical Records - Electronic medical record software provider adds pediatric content to system

Electronic Medical Records - Health benefits company launches secure personal health record feature online

Electronic Medical Records - Survey shows majority of consumers believe EMRs can improve medical care

Epilepsy - FDA approval for VNS therapy provides potential 2-in-1 treatment for epilepsy

Epilepsy Treatments - Levetiracetam doesn't affect pharmacokinetics of adjunctive drugs

Erythromyalgia - Findings of Yale study on primary EM linking gene mutation to pain published

Finance - Allergy vaccine maker provides trading update

Finance - American Stock Exchange lists stock of China-based pharma firm

Finance - BioInnovation SA commercial infrastructure grant awarded

Finance - Biopharmaceutical firm closes $8.5M private placement

Finance - Biopharmaceutical firm raises $36M in series B financing

Finance - Biotech company closes $20.4 million series C private financing

Finance - Biotech company reports 66% increase in sales

Finance - Biotech firm's earnings per share increased 42% to $0.88

Finance - Biotechnology company developing stem cell therapeutics grants stock options

Finance - Blood plasma volume expander maker has new trading symbols

Finance - Brachytherapy-focused corporation reports Q2 2005 consolidated financial results

Finance - Cancer-, blood-focused pharmaceutical company reports Q2 2005 financial results

Finance - Company reports strong earnings growth of 28% to $0.46 per share

Finance - Cord blood bank company reports 12% increase in revenue

Finance - Cubicin maker reports Q2 net product revenues of $25.6M, up 23% over Q1

Finance - Developer of DNA-binding protein therapeutics reports Q2 2005 financial results

Finance - Developer of immune system-based therapies announces quarterly dividend

Finance - Drug delivery, diagnostics company reports Q3 results, record revenue, earnings

Finance - GSK makes equity investment in oncology company

Finance - Generic drug company announces record Copaxone sales of $291 million in Q2

Finance - Generic drugs company reports results for first 6 months of 2005

Finance - Healthcare financial data show venture capital slumping, acquisitions shifting

Finance - Healthcare products company reports 11.1% increase sales increase in Q2 2005

Finance - Healthcare products corporation reports financial results for Q2 2005

Finance - Heart device company reports second quarter sales and earnings

Finance - Immune-based biopharmaceutical corporation signs $15 million financing agreement

Finance - Immunotherapy maker raises $0.5M in new equity

Finance - Inhaled drug maker's common stock to be delisted from NASDAQ

Finance - Laboratory company announces Q2 2005 results

Finance - Laboratory testing services company reports Q2 2005 financial results

Finance - Lexapro maker reports Q1 dip in revenues

Finance - Medical device company raises $30 million in preferred equity financing

Finance - Medical products company reports financial performance for second quarter 2005

Finance - Medical transcription company reports 74% revenue increase, $0.03 per share loss

Finance - Nanotechnology company reports loss of $0.38 per share

Finance - Neuroscience company announces $17.7M series A financing

Finance - Nutritionals, weight management products company reports Q2 2005 sales, profits

Finance - Orthopedics company reports operating results for quarter ended June 30, 2005

Finance - Orthopedics device provider prices equity offering

Finance - Pharma firm sets pricing for public offering

Finance - Pharma firm to redeem 4.75% convertible subordinated notes due 2007

Finance - Pharma firm's second quarter net income up 22%

Finance - Pharmaceutical company raises $6M in series A financing

Finance - Pharmaceutical company records loss of $0.46 per share

Finance - Pharmaceutical company reports loss of $0.59 per share

Finance - Pharmaceutical firm raises $60M

Finance - Pharmaceutical firm reports loss of $0.06 per share

Finance - Pharmaceutical firm reports option grants

Finance - QUADRAMET maker to raise $14 M through sale of common stock and warrants

Finance - Scios Inc. announces redemption of 5.50% debentures due August 2009

Finance - Specialty-pharmaceutical company reports increased net sales in Q2

Finance - U.S. NIH funding used for production of a thermostable cholera vaccine

Finance - Vascular device company announces profitability and record Q2 2005 results

Finance - Virus-focused biopharmaceutical company reports Q2 2005 financial results

Food Safety - Canadian marketing approval received on DNA IHNV virus vaccine for salmon

Food Safety - Lateral flow test approved for testing corn for aflatoxin

Gene Research - Studies may target new drugs for three parasites with common genetic core

Gene Research - The newly identified gene Egfl7 helps maintain endothelial integrity

Gene Research - Tobacco research group, genetics company set joint U.S. field trial experiment

Generic Drugs - Generic antibiotic ceftriaxone injection to become available

Generic Drugs - Pharma company receives FDA approval to manufacture Ibuprofen Tablets

Generic Drugs - U.S. FDA grants tentative approval of generic antihistamine tablet

Genetics & Genomics - Accelerated Technologies Center for Gene to 3D Structure established

Genetics & Genomics - Consortium to receive a genome-wide siRNA library

Genomics - Biotech company's research on gene expression patterns in the brain complete

Gynecology - Company announces updated labeling for Mifeprex

HIV Therapy - Pharma company receives U.S. FDA approval for Zidovudine Tablets

HIV/AIDS Drug Development - New drug targets for HIV needed

HIV/AIDS Drug Development - Small molecule inhibitor of ATM kinase suppresses drug-resistant HIV-1 infection

HIV/AIDS Prevention - U.S. Senate increases microbicide funding for a total of $42 million

HIV/AIDS Therapy - FDA grants fast track status for investigational HIV protease inhibitor

HIV/AIDS Therapy - Studies identify immature HIV virus as new target for drug design

HIV/AIDS Therapy - Uganda first lady, foundation president dedicate AIDS clinic in Kampala market

HIV/AIDS Treatment - Phase 2b dosing begun in monotherapy trial for 'oral entry inhibitor' HIV drug

HIV/AIDS Vaccine - Discovery and development services company awarded NIH contract

HIV/AIDS Vaccine - Prime-boost regimen enhances potency of DNA HIV vaccines

Healthcare Access - Agreement with HCA to purchase 5 hospitals in Virginia, West Virginia signed

Healthcare Access - Long-term care facilities company announces plans for 2 new hospitals

Healthcare Access - Survey on emergency care results reported

Healthcare Coverage - Pharmacy benefit management group reports 7.2% drug trend in 2004 report

Healthcare Coverage - U.S. CMS approves benefits company's managed care coverage expansion

Hepatitis B Virus - Biopharmaceutical company comments on data from hepatitis B treatment study

Hepatitis B Virus - Phase III clinical evaluation of tenofovir disoproxil fumarate begins

Herpes Labialis - Phase 2 study of herpes labialis treatment successfully completed

Hypertension - Enrollment completed in trial of pulmonary arterial hypertension treatment

Imaging - Brachytherapy planning tool streamlines prostate cancer treatments

Infectious Diseases - Infectious disease institute, DNA technologies developer sign research agreement

Influenza Vaccine - Drug manufacturer to increase U.S. influenza vaccine capacity with new plant

Influenza Vaccine - Pharma company files for new indication of Tamiflu in Europe

Information Technology - Aetna supports program giving NJ physicians access to electronic prescribing

Information Technology - Cancer therapy systems company teams with Onco, Inc. to offer registry software

Information Technology - Free online health assessment from the American Diabetes Association available

Information Technology - Maryland hospital picks claims, remittance, denial management electronic system

Information Technology - Massachusetts medical group signs 3-year contract for IT management system

Information Technology - Pharmacy franchisor to provide discounts on electronic prescribing transactions

Information Technology - RFID technology prevents infant abduction at NC hospital, company reports

Information Technology - Wisconsin IT company launches electronic health record image viewer system

Insomnia - Study of insomnia therapy in perimenopause-menopausal women shows improvement

Legal Issues - Medical device company reports unfavorable outcome of arbitration proceedings

Legal Issues - Medical devices company wins appeal in patent infringement case

Legal Issues - Pharma company reaches settlement with Connecticut on pricing litigation

Lipid Research - Once-daily oral treatment for lipid disorders, cholesterol launched in U.S.

Lower Back Pain - Research shows low level heat wrap therapy helps low back pain

Market Analysis - Pharma competitive intelligence groups report to marketing

Marketing - Cancer drugs drive pharmaceutical success, claim marketing dollars

Marketing - Parent company to launch new markets through medical imaging subsidiary

Marketing - Zonegran maker launches pharmaceutical marketing subsidiary in Sweden

Medicaid - Collaboration formed to educate Medicaid beneficiaries on options

Medicaid - Georgia community health department awards Medicaid managed care contracts

Medical Devices - Army medical center acquires blood volume analyzer for use in burn center

Medical Devices - First total marrow irradiation using conformal delivery device performed

Medical Devices - Health system consortium signs new 3-year SUDS reprocessing, recycling agreement

Medical Devices - ISO certification issued for medical device company

Medical Devices - Medical device association applauds senate committee action

Medical Devices - Medical device company releases two new catheters

Medical Devices - Medical device deals and funding increasing, healthcare financial publisher says

Medical Devices - Study on XLIF minimally disruptive spine surgery procedure presented

Medical Devices - U.K. health institute approves PVP procedure at health service hospitals

Medical Devices - sNDA filed for Biojector 200 in FUZEON administration

Medicare - Prescription drug benefit is on the way for patients with limited income

Medicare - Survey shows cholesterol tests of Medicare patients on the rise

Menopause - Pharmaceutical company launches educational campaign about menopause for women

Mental Health - Aetna and GlaxoSmithKline cosponsor depression seminars for employers

Mental Health - Study finds animal assisted therapy can help troubled youth

Mergers & Acquisitions - Agreement reached for acquiring Greenwich Therapeutics, anti-cancer compounds

Mergers & Acquisitions - Bankruptcy court approves company's bid to acquire pain management portfolio

Mergers & Acquisitions - Biotech company exercises rights in Prima BioMed, Ltd.

Mergers & Acquisitions - Information source, systems provider to healthcare industry to merge

Mergers & Acquisitions - Japanese biopharmaceutical company to acquire Arakis for over $187 million

Mergers & Acquisitions - Manufacturer of Chinese herbal medicines completes merger with Child Vision, Inc

Mergers & Acquisitions - Oncology, acute care-focused company to acquire Guilford Pharmaceuticals, Inc.

Mergers & Acquisitions - Pennsylvania healthcare provider acquires eighth specialty rehab hospital

Mergers & Acquisitions - Pharma company acquires GlycArt Biotechnology

Mergers & Acquisitions - Pharma company acquires QdotPharma

Mergers & Acquisitions - Pharma company to acquire OTC brand portfolio from Bristol-Myers Squibb

Mergers & Acquisitions - Pharma services company and Aptuit enter strategic partnership

Mergers & Acquisitions - Three Quintiles Transnational business units to be acquired

Metastatic Melanoma - Human trial of gene-based interleukin-2 with electroporation technology begun

Multiple Sclerosis - Foundation raises first $5 million for multiple sclerosis research

Multiple Sclerosis - Two-year study of Tysabri with Avenox reinforces efficacy in multiple sclerosis

Mycoplasma Gallisepticum Vaccine - Response of broiler breeders after Mycoplasma vaccination evaluated

Nanotechnology - Antibiotic development program uses nanoparticle delivery platform

Neuroscience - Adult stem cell breakthrough for neurodegenerative diseases reported

Nosocomial Infections - Shower filter helps protect against waterborne pathogens

Oncology - Study of oncologists' use of cancer treatments, correlation with perceptions set

Osteoporosis - Phase I clinical trial for osteoporosis complete

Pain Management - U.S. NIH awards $197,000 grant to develop drug candidate for neuropathic pain

Parkinson Disease - Pharmaceutical company completes Parkinson disease trial

Patents - Biotech company issued patent for method of producing infectious reovirus

Patents - Cardiology device company reaches settlement with university patent foundation

Patents - Company files for U.S. patent for wireless home sleep apnea test

Patents - European patent issued for target discovery technology

Patents - Pharma company issued patent for lingual spray technology

Patents - U.K. grants patent for sensitive 'Cannabis' detection method

Patents - U.S. Patent Office grants patent for fluorescence endoscopy compact camera

Patents - U.S. patent granted for asthma treatment

Patient Safety - Guardlid launched as new child-resistant pharmaceutical packaging solution

Pediatric Vaccine - Number of injections can lead to missed vaccination opportunities

Personnel - August Watanabe, MD, named nonexecutive chair of drug discovery company board

Personnel - Barry A. Labinger named executive VP and chief commercial officer

Personnel - Biomedical company appoints Ronald W. Mink chief science officer

Personnel - Biopharma company appoints member to board

Personnel - Biopharmaceutical company establishes sickle cell advisory board

Personnel - Biotech company names Jeffrey Skulsky VP, MIS

Personnel - Biotech company strengthens finance, clinical, quality management team

Personnel - Biotech group names chairman, board members for 2005-2006

Personnel - Bruce C. Hayden named chief financial officer by medical staffing company

Personnel - Cancer diagnostic devices company announces U.S., European sales management team

Personnel - Cancer diagnostic devices company names Rob Ngungu VP, quality, clinical affairs

Personnel - Disease management company names David Hollis, MD, chief medical officer

Personnel - Drug discovery company appoints new scientific advisory board

Personnel - Eve Slater, Kevin Reilly named to board of infection-focused biopharm company

Personnel - Generic pharma company announces board member resignations

Personnel - Healthcare company announces new member of board of directors

Personnel - Imaging company names Dr. Neil Dey VP of business development, marketing

Personnel - James L. Vincent named director at biopharmaceutical company

Personnel - Jim Vannelle named VP of market development by hospice care provider

Personnel - John M. Taylor III appointed to government affairs staff at pharma firm

Personnel - Joseph P. Campanelli named chairman of the board by academic medical institution

Personnel - Kimberly Popovits joins board of directors

Personnel - Kiyotaka Fujii named president, CEO by provider to healthcare, pharma industries

Personnel - Lawrence F. Bruder elected president, chief operating officer by biotech company

Personnel - Michael A. Fauman, MD, PhD, appointed to APA psychiatric diagnosis committee

Personnel - Ophthalmic products maker names Mark H. Karsch CFO

Personnel - Pharma company appoints general counsel

Personnel - Pharma company transitions board chair position

Personnel - Pharmaceutical company adds Lynn Smiley as chief medical officer

Personnel - Pharmaceutical company announces management appointments

Personnel - Pharmaceutical company appoints William Peters to board

Personnel - Pharmaceutical company strengthens its sales and marketing team

Personnel - Pharmaceutical firm appoints Carol Raphael to board of directors

Personnel - Richard J. Welter, PhD, named VP business development by pharmaceutical company

Personnel - Sue Bailey joins scientific advisory board of recombinant human enzymes company

Personnel - Supplier of healthcare personnel retains new professionals

Personnel - Surgeons' group selects president-elect

Personnel - Terry Hill named director, quality assurance and control by bio implant company

Pharmaceutical Research - Biologic treatments help improve quality of life for psoriasis patients

Pharmaceutical Research - Early access program launched for new line of genotyping assays

Pharmaceutical Research - Study examines pharma product lifecycle management

Product Licensing - Companies ink PER.C6 licensing agreement with Symphogen

Product Licensing - Generic HIV/AIDS efavirenz license granted to African manufacturer

Product Licensing - License granted to fundamental RNAi patents

Product Licensing - Life science company offering tools to contract research organizations

Product Licensing - Life sciences company licenses fundamental RNAi patent estate from Alnylam

Prostate Cancer - Centers begin study of prostate cancer patients receiving radiation therapy

Prostate Cancer - Pharma company initiates phase I study of RC-8800 for prostate cancer

Prostate Cancer - Phase 2 clinical trials of OGX-011 for prostate cancer initiated

Prostate Cancer - Supply agreement announced Prospera palladium-103 prostate brachytherapy

Prostate Cancer - Symposium on high intensity focused ultrasound treatment for prostate cancer

Proteomics - Antibody array to identify protein kinase expression in cell, extracts launched

Proteomics - Bioscience company offers Protran nitrocellulose membranes for protein research

Proteomics - Compounds could lead to agents with hypotensive and lipid-lowering properties

Proteomics - Maryland companies sign marketing agreement for protein immunodetection products

Psoriasis - American version of PSORIQoL test developed

RNA Research - Company to explore uses for new ribonuclease drug candidate

RNA Research - Dozens of novel human microRNAs identified

RNA Research - Papers identify human kinases involved in endocytosis

Renal Cell Carcinoma - Sorafenib NDA filing completed for advanced renal cell carcinoma indication

SARS - SARS Neugene antisense studies published

Sexual & Reproductive Health - National institute accepts clinical trial of female sexual dysfunction treatment

Smallpox Vaccine - Phase 1/2 study of attenuated smallpox vaccine candidate completes enrollment

Stem Cell Research - Biopharm company gets $35 million to create mouse embryonic stem cell library

Stem Cell Research - U.S. bone graft trial expanded to include University of Nebraska Medical Center

Stomach Cancer - From thousands of genes to a single compelling new target

Stroke - Monkey model of thrombotic middle cerebral artery occlusion developed

Systemic Lupus Erythematosus - Phase I study of 57-57 for Systemic Lupus Erythematosus complete

Tobacco Use - Enrollment completed in study of vaccine to prevent and treat nicotine addiction

Tobacco Use - Health plan company HMO physicians use U.S. PHS 5 A smoking cessation program

Tobacco Use - Minnesota tobacco organization board approves new stop-smoking center grants

Tuberculosis Vaccine - Single M. tuberculosis antigen protects against tuberculosis

Type 1 Diabetes - Intellectual property agreement signed for anti-CD3

Type 2 Diabetes - Pharma company initiates trial of PSN357

Type 2 Diabetes - Study evaluating drug impact on type 2 diabetes patient treatment completed

Type 2 Diabetes - Study reaffirms Diachrome improves cardiovascular disease risk in diabetes

Type 2 Diabetes - Study shows slowdown after active service puts some vets at risk for diabetes

Urology - Company updates U.S. FDA pre-market approval submission for incontinence implant

Vaccine Vector - Packaging cell line for production of lentiviral vector generated

Venous Ulcers - FDA approves protocol and initiation of confirmatory trial of OrCel

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx